CASE REPORT
Published on 16 Dec 2024
Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy
doi 10.3389/fphar.2024.1528541
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Dysfunctions in GABAergic Signaling in Neurological Disorders
Dysfunctions in GABAergic Signaling in Neurological Disorders
710
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 710Topic views
- 45Article views